Presentation of our pharmaceuticals industry line of services

1. Pharmaceuticals
Business is becoming more competitive in the pharmaceuticals industry today. Even though
drug development takes less time, the cost of bringing these new products to market is on the
rise.
You're launching new products on a global scale.
You're currently making important decisions on research and development issues for the
future, and,
You’re looking to improve your research and development ratios through strategic
alliances with biotech companies, universities and hospitals.
CBM is here to assist you in achieving and sustaining success within the pharmaceuticals
industry, today and for tomorrow.
For the challenges you face…
These days, you're subject to higher levels of public scrutiny and regulatory control. We know
the pressure you're under. We know the issues you're facing. They include:
Growth in managed care;
Changing customer demand;
Regulatory constraints;
Patent expiry;
Increasing price pressures;
High R&D costs;
Growing demand for generics;
Expanding growth in biotechnology;
Consolidation; and
Outsourcing.
The business climate for biotechnology and pharmaceutical companies throughout the world
has undergone fundamental changes. Cross-border mergers & acquisitions and corporate
strategic partnerships are now key to get a critical size on international markets, and
companies continue to explore new foreign markets at a time while volatility is increasing.
Product and regulatory liabilities have become seemingly open-ended. Global competition
and business activities are intensifying. Market pressures and looming patent expirations
continue to present challenges.
Produit exclusif CBM – Reproduction partielle ou totale interdite sans accord préalable écrit

2. Plaquette de Présentation Page 2 / 2
As the face of the industry transforms, companies must develop creative strategies to become
and remain profitable.
Access to multi-distribution channels and the use of innovative marketing concepts will
be critical, as will research and development, and the retention of human capital.
A comprehensive information technology strategy must be part of every company's
internal makeover. And, of course,
Successful companies will continue their ongoing focus on the fundamentals: increasing
productivity and managing costs.
The pharmaceutical industry, one of the most profitable of all industries, is poised for
continued, albeit slower, growth.
Spending on prescription drugs is spurred by favorable demographics - aging but longer-
lived baby-boomers are consuming increasing numbers and quantities of drugs for health
and lifestyle reasons.
Changing medical practices, and the focus on preventive medicine, are also giving drugs
a boost.
Cost containment measures are combined with divestiture of non-core or less profitable
businesses to improve company performance while patent expiration of major
blockbuster drugs means competition is expanding into pharmaceutical markets at an
accelerating pace, limiting ultimately profits. And, on the top of it, pressure is on to bring
drug prices under control as managed health organizations, government health systems
and consumers bend under the weight of spiraling costs.
…we're focused on Your issues
At CBM, our professionals understand the critical issues to provide growth and development
to biotechnology and pharmaceutical companies. Through our experience serving many of the
world's leading corporations, CBM is attuned to leading practices throughout these sectors (or
this industry). We bring these insights to our clients providing:
innovative strategies to help them succeed in a complex business environment.
practical solutions to help them cut costs, improve operations and succeed in a complex
and competitive world.
Produit exclusif CBM – Reproduction partielle ou totale interdite sans accord préalable écrit